Molecular typing and antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium in Brazil

Infection Control and Hospital Epidemiology

Volumn 23, Issue 1, 2002, Pages 19-22

  Cereda, Rosangela F ^a   Gales, Ana C ^a   Silbert, Suzane ^a   Jones, Ronald N ^b   Sader, Helio S ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; GENTAMICIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BRAZIL; ENTEROCOCCUS FAECIUM; HOSPITAL; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS;

EID: 0036168005     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/501962     Document Type: Article

References (23)

1. Vancomycin-resistant enterococci: An emerging pathogen in immunosuppressed transplant recipients
2. Resistance to glycopeptides in enterococci
3. In vitro antimicrobial activity against enterococci isolated in a university hospital in Sao Paulo, Brazil
4. Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada)
5. Survey of blood stream infections attributable to gram-positive cocci: Frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program
6. Results of the SENTRY Antimicrobial Surveillance Program in three Brazilian medical centers for 1997
7. Vancomycin-resistant Enterococcus faecium: First case in Brazil
8. Antimicrobial susceptibility of quinupristin-dalfopristin tested against gram positive cocci from Latin America: Results from the Global SMART (GSMART) Surveillance Study
9. Enterococcus
10. PA, National Committee for Clinical Laboratory Standards (NCCLS) Performance Standards for Antimicrobial Susceptibility Testing Tenth Informational Supplement M100-S10 Wayne, National Committee for Clinical Laboratory Standards
11. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR
12. Mechanisms of resistance to quinupristin-dalfopristin among isolates of Enterococcus faecium from animals, raw meat, and hospital patients in Western Europe
13. Characterization of a new enterococcal gene, satG, encoding a putative acetyltransferase conferring resistance to streptogramin A compounds
14. Chromosomal restriction fragment analysis by pulsed-field gel electrophoresis
15. Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada
16. Characterization of a divergent vanD-type resistance element from the first glycopeptide-resistant strain of Enterococcus faecium in Brazil
17. Mechanism of action of streptogramins and macrolides
18. Evaluation of interhospital spread of methicillin-resistant Staphylococcus aureus in São Paulo, Brazil, using pulsed-field gel electrophoresis of chromosomal DNA
19. Low prevalence of patients colonized with vancomycin-resistant enterococci in spite of high use of vancomycin
20. Recommendations for preventing the spread of vancomycin resistance: Recommendations of the Hospital Infection Clinical Practices Advisory Committee (HICPAC)
21. Evaluation and characterization of multiresistant Enterococcus faecium from twelve U.S. medical centers